Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Movement disorders in 2012

Advancing research towards novel therapeutic approaches

Research in movement disorders in 2012 has improved our understanding of the pathogenic mechanisms of disease and led to development of potential novel therapeutic approaches. Key advances were linked to mechanisms underlying spread of neurodegenerative pathology, immunotherapy, stem cells, genetics and deep brain stimulation in parkinsonism and related disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197–211 (2003).

    Article  Google Scholar 

  2. Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp. Med. 209, 975–986 (2012).

    Article  CAS  Google Scholar 

  3. Masliah, E. et al. Effects of α-synuclein immunization in a mouse model of Parkinson's disease. Neuron 46, 857–868 (2005).

    Article  CAS  Google Scholar 

  4. Masliah, E. et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS ONE 6, e19338 (2011).

    Article  CAS  Google Scholar 

  5. Bae, E. J. et al. Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission. J. Neurosci. 32, 13454–13469 (2012).

    Article  CAS  Google Scholar 

  6. Lee, P. H. et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann. Neurol. 72, 32–40 (2012).

    Article  Google Scholar 

  7. An, M. C. et al. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11, 253–263 (2012).

    Article  CAS  Google Scholar 

  8. Okun, M. S. et al. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. Arch. Neurol. 8, 1–10 (2012).

    Google Scholar 

  9. Little, S., Pogosyan, A., Kuhn, A. A. & Brown, P. β band stability over time correlates with Parkinsonian rigidity and bradykinesia. Exp. Neurol. 236, 383–388 (2012).

    Article  CAS  Google Scholar 

  10. Maling, N., Hashemiyoon, R., Foote, K. D., Okun, M. S. & Sanchez, J. C. Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome. PLoS ONE 7, e44215 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

N. R. McFarland is supported by the National Institute of Neurological Disorders and Stroke. M. S. Okun is funded by the National Parkinson Foundation and the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael S. Okun.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McFarland, N., Okun, M. Advancing research towards novel therapeutic approaches. Nat Rev Neurol 9, 70–71 (2013). https://doi.org/10.1038/nrneurol.2012.265

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2012.265

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing